Altitude Ventures Management, LLC
Altitude Life Science Ventures Fund IV, L.P.
Follow-ons only
Follow-ons only: no first sale reported; age from Form D filed Oct 2020 (approximate)
- Vintage
- Unknown
- Fund size
- $150M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
Altitude Life Science Ventures Fund IV, L.P. holds early-stage life science companies across therapeutics, gene editing, and AI-driven science. The fund page lists its portfolio companies.
02 · Initial check
$1.5M to $2.5M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Dave Maki, Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Holds early-stage life science companies across therapeutics, gene editing and AI-driven science. The fund page lists the portfolio companies.
Generate Biomedicines GENB -- initial public offering February, 2026
https://www.altitudelsv.com/fund-iv
06 · Sources
Last verified: Oct 25, 2026